ACTA SCIENTIFIC CLINICAL CASE REPORTS

Case Report Volume 5 Issue 10

Longitudinally Extensive Transverse Myelitis in a Systemic Lupus Erythematosus Patient

Wiem Romdhane*, Maissa Thabet, Ahmed Guiga, Wissal Ben Yahia, Amira Atig and Neirouz Ghannouchi

Internal Medicine Department, Farhat Hached University Hospital, Tunisia

*Corresponding Author: Wiem Romdhane, Internal Medicine Department, Farhat Hached University Hospital, Tunisia.

Received: June 25, 2024; Published: September 24, 2024

Abstract

Longitudinally extensive transverse myelitis (LETM) is a rare and devastating type of Transverse myelitis (TM) that involves at least three contiguous vertebrae on T2-weighted magnetic resonance imaging (MRI). It occurs in different infectious, traumatic and autoimmune diseases such as Systemic lupus erythematosus (SLE). Herein, we report a case of lupus flare with a severe outcome as LETM with literature review. A 32-year-old woman with eleven-year-history of well controlled SLE, was hospitalized in our department with chronic fever evolving for two months and appearing 48 hours after uncomplicated vaginal delivery. The patient experienced tetra paresis with paresthesia and urinary retention. MRI of the spine showed intramedullary T2–weighted hyper-intense signals extended longitudinally to more than 9 vertebral segments and enlargement of the spinal cord, suggestive of LETM. Cerebral MRI in axial flair image showed nonspecific bilateral fronto-parietal white matter hyperintensities. The patient received methylprednisolone 1 g/day for 5 days, relayed by oral prednisolone 1 mg/kg/d and cyclophosphamide (1g/month) during 6 months with functional physiotherapy. The evolution was marked by a complete regression of paresis and paresthesia in limbs and urinary sphincter disorder.

Keywords: Longitudinally Extensive Transverse Myelitis; Transverse Myelitis; Systemic Lupus Erythematosus

References

  1. Sarwar S., et al. “Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges”. Cureus9 (2021): e17969.
  2. Zardi EM., et al. “Diagnostic approach to neuropsychiatric lupus erythematosus: what should we do?” Postgraduate Medicine 6 (2018): 536-547.
  3. Chiganer EH., et al. “Transverse Myelitis in Systemic Lupus Erythematosus: Clinical Features and Prognostic Factors in a Large Cohort of Latin American Patients”. Journal of Clinical Rheumatology6S (2021): S204-S211.
  4. Zhang W., et al. “Etiological, clinical, and radiological features of longitudinally extensive myelopathy in Chinese patients”. Journal of Clinical Neuroscience 32 (2016): 61-66.
  5. Stahl NI., et al. “Fever in systemic lupus erythematosus”. The American Journal of Medicine 67 (1979): 935-940.
  6. Rovin BH., et al. “Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy”. Kidney International2 (2005): 747-759.
  7. Jain RS., et al. “Longitudinally extensive transverse myelitis: A retrospective analysis of sixty-four patients at tertiary care center of North-West India”. Clinical Neurology and Neurosurgery 148 (2016): 5-12.
  8. Guerra H., et al. “Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies”. Mayo Clinic Proceedings9 (2018): 1299-1304.
  9. Tavor Y., et al. “Longitudinally Extensive Transverse Myelitis in a Lupus-NeuromyelitisOptica Overlap”. Rambam Maimonides Medical Journal1 (2021): e0006.
  10. Bertsias GK., et al. “EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs”. Annals of the Rheumatic Diseases12 (2010): 2074-2082.

Citation

Citation: Wiem Romdhane., et al. “Longitudinally Extensive Transverse Myelitis in a Systemic Lupus Erythematosus Patient". Acta Scientific Clinical Case Reports 5.10 (2024): 21-24.

Copyright

Copyright: © 2024 Wiem Romdhane., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days
Impact Factor1.014

Indexed In